In a wide-ranging Becker’s Healthcare podcast, the CEO of The Permanente Medical Group shares his views on his path to leadership, telehealth, and how the COVID-19 pandemic will transform health care.
Stephen Parodi, MD, executive vice president of The Permanente Federation and national infectious disease leader at Kaiser Permanente, recently discussed the effects of disparate approaches to COVID-19 interventions across the United States with The Wall Street Journal.
Shari Chevez, MD, a pediatrician and regional lead for equity, inclusion, and diversity with the Southern California Permanente Medical Group, recently shared insights in the American Medical Association (AMA) COVID-19 Update video series on how and why COVID-19 is having a disproportionate impact on the Latinx community.
Nancy Gin, MD, recently told Healthline that it is important for people to be careful and candid about where they’ve been and where they are going now that they’re doing some “cautious toe dipping” in public settings as states reopen.
Stephen Parodi, MD, national infectious disease leader for Kaiser Permanente, commented in Fierce Healthcare on Kaiser Permanente’s multipronged COVID-19 suppression strategy, which was outlined in a NEJM Catalyst article earlier this week. That strategy includes 8 key capabilities health systems need to consider as the country reopens.
In an article published this week in NEJM Catalyst, Kaiser Permanente physicians and leaders acknowledge the conundrum of reopening the country for business while preventing successive waves of coronavirus infection, and describe the next strategic phase in the battle against the COVID-19 pandemic: disease suppression.
As civil unrest sparks action across the nation, many members of the medical community are taking part in the conversation.
Despite its massive human toll, the COVID-19 pandemic can serve as a catalyst for reimagining the future of health care delivery, Imelda Dacones, MD, wrote in a recent opinion piece posted on KevinMD.com.
While the federal government’s temporary pause on quality reporting during the COVID-19 pandemic may provide an opportunity to reevaluate and streamline its requirements, such streamlining should ultimately contribute to quality outcomes for patients, Nancy Gin, MD, said in a recent interview with Modern Healthcare.
Vincent Liu, MD, a specialist in critical care medicine with The Permanente Medical Group, commented on a Kaiser Permanente study that found important differences in outcomes among hospitalized COVID-19 patients in the western United States and other parts of the world.